• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    13.21 Down 0.59(4.28%) Dec 19, 4:00PM EST
    |After Hours : 13.55 Up 0.34 (2.57%) Dec 19, 7:48PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 14,219   37,329   46,990  
    Cost of Revenue -   -   -  
    Gross Profit 14,219   37,329   46,990  
    Operating Expenses
    Research Development72,909  52,402  66,862  
    Selling General and Administrative31,594  14,630  16,055  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (90,284) (29,703) (35,927)
    Income from Continuing Operations
    Total Other Income/Expenses Net(22,027)(91,938)33,022  
    Earnings Before Interest And Taxes(111,985)(121,287)(2,318)
    Interest Expense -   -   -  
    Income Before Tax(111,985)(121,287)(2,318)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(111,985)(121,287)(2,318)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (111,985) (121,287) (2,318)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (111,985) (121,287) (2,318)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.